The "Virtual" Reality of Drug Discovery at Novartis
A conversation between Edgardo Leija, Chief Experience Officer at Nanome, and Wilian Cortopassi, Senior Expert in Data Science I (Principal Scientist I) at Novartis Institutes for BioMedical Research (NIBR).
What will you learn?
Join our speakers for a discussion and Q&A about the "virtual" reality of drug discovery at Novartis:
How Novartis is using Virtual Reality across different research sites globally (US and Switzerland)
A case study of the main protease (Mpro) of SARS-CoV-2
Future outlook of VR at Novartis